BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 10504797)

  • 21. Positron emission tomography in oncology.
    Lobrano MB; Singha P
    Clin J Oncol Nurs; 2003; 7(4):379-85. PubMed ID: 12929270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical applications of (18)F-FDG in oncology.
    Nabi HA; Zubeldia JM
    J Nucl Med Technol; 2002 Mar; 30(1):3-9; quiz 10-1. PubMed ID: 11948260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.
    Macfarlane DJ; Cotton L; Ackermann RJ; Minn H; Ficaro EP; Shreve PD; Wahl RL
    Radiology; 1995 Feb; 194(2):425-9. PubMed ID: 7824722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Positron emission tomography in the Netherlands: need to expand the capacity].
    Comans EF; Smit EF
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1817-9. PubMed ID: 12382364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. F-18-FDG positron imaging in oncological patients: gamma camera coincidence detection versus dedicated PET.
    Zimny M; Kaiser HJ; Cremerius U; Sabri O; Schreckenberger M; Reinartz P; Büll U
    Nuklearmedizin; 1999; 38(4):108-14. PubMed ID: 10392375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The applications of PET in clinical oncology.
    Strauss LG; Conti PS
    J Nucl Med; 1991 Apr; 32(4):623-48; discussion 649-50. PubMed ID: 2013803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical oncologic positron emission tomography: an introduction.
    Turkington TG; Coleman RE
    Semin Roentgenol; 2002 Apr; 37(2):102-9. PubMed ID: 12134363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDG imaging of lung nodules: a phantom study comparing SPECT, camera-based PET, and dedicated PET.
    Coleman RE; Laymon CM; Turkington TG
    Radiology; 1999 Mar; 210(3):823-8. PubMed ID: 10207487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is new in nuclear medicine imaging?
    Ferrand SK; Chen CC; Dilsizian V; Neumann RD
    Surg Oncol Clin N Am; 1999 Jan; 8(1):185-204. PubMed ID: 9824368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron emission tomography: clinical applications in oncology. Part 1.
    Kumar R; Nadig MR; Chauhan A
    Expert Rev Anticancer Ther; 2005 Dec; 5(6):1079-94. PubMed ID: 16336099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Appropriate use of positron emission tomography with [(18)F]fluorodeoxyglucose for staging of oncology patients.
    Tagliabue L; Del Sole A
    Eur J Intern Med; 2014 Jan; 25(1):6-11. PubMed ID: 23910561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
    Delbeke D
    J Nucl Med; 1999 Apr; 40(4):591-603. PubMed ID: 10210218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET imaging in oncology.
    Bar-Shalom R; Valdivia AY; Blaufox MD
    Semin Nucl Med; 2000 Jul; 30(3):150-85. PubMed ID: 10928381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.
    Freudenberg LS; Schueler AO; Beyer T; Antoch G; Kühl H; Bornfeld N; Bockisch A; Egelhof T
    Surv Ophthalmol; 2004; 49(5):537-40. PubMed ID: 15325198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of 18FDG positron emission tomography in detection and follow-up of digestive cancers.
    Paulus P; Hustinx R; Daenen F; Jacquet N; Rigo P
    Acta Gastroenterol Belg; 1997; 60(4):278-80. PubMed ID: 9529672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods].
    Pichler R; Maschek W; Hatzl-Griesenhofer M; Huber H; Wimmer G; Wahl G; Fridrik M
    Nuklearmedizin; 2000 Sep; 39(6):166-73. PubMed ID: 11057408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nodal staging of lymphoma with whole-body PET: comparison of.
    Sutinen E; Jyrkkiö S; Varpula M; Lindholm P; Grönroos T; Lehikoinen P; Teräs M; Minn H
    J Nucl Med; 2000 Dec; 41(12):1980-8. PubMed ID: 11138682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positron emission tomography scanning: current and future applications.
    Czernin J; Phelps ME
    Annu Rev Med; 2002; 53():89-112. PubMed ID: 11818465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of positron emission tomography in oncology.
    Glaspy JA; Hawkins R; Hoh CK; Phelps ME
    Oncology (Williston Park); 1993 Jul; 7(7):41-6, 49-50; discussion 50-2, 55. PubMed ID: 8347460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.